"Therapy with hydrochlorothiazide and spironlactone decreases the risk of calcium oxalate precipitation in premature infants" by Thomas Campfield, MD

Article

Therapy with hydrochlorothiazide and spironlactone decreases the risk of calcium oxalate precipitation in premature infants

All Scholarly Works

Thomas Campfield, MD, Baystate Health
Gary Rockwell, MD, Baystate Health
Gregory Braden, MD, Baystate Health

Document Type

Presentations, Research

Publication Date

5-1-2010

Citation Information

Rockwell G, Eaton L, Klein D, Braden G, Campfield T. Therapy with hydrochlorothiazide and spironlactone decreases the risk of calcium oxalate precipitation in premature infants. Society for Pediatric Research Annual Meeting. Vancouver, Canada. May 1-May 4, 2010.